BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37779718)

  • 1.
    Yang W; Yang H; Bao X; Hussain M; Bao Q; Zeng Z; Xiao C; Zhou L; Qin X
    Front Microbiol; 2023; 14():1198747. PubMed ID: 37779718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Edeine B
    Kim B; Nguyen MV; Park J; Kim YS; Han JW; Lee J-Y; Jeon J; Son H; Choi GJ; Kim H
    mBio; 2024 Jun; ():e0135124. PubMed ID: 38860787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a pathway-specific activator of edeine biosynthesis and improved edeine production by its overexpression in
    Du J; Zhang C; Long Q; Zhang L; Chen W; Liu Q
    Front Plant Sci; 2022; 13():1022476. PubMed ID: 36388555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brevibacillus fortis NRS-1210 produces edeines that inhibit the in vitro growth of conidia and chlamydospores of the onion pathogen Fusarium oxysporum f. sp. cepae.
    Johnson ET; Bowman MJ; Dunlap CA
    Antonie Van Leeuwenhoek; 2020 Jul; 113(7):973-987. PubMed ID: 32279200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of edeine production in Brevibacillus brevis X23 via in situ promoter engineering.
    Liu Q; Zhang L; Wang Y; Zhang C; Liu T; Duan C; Bian X; Guo Z; Long Q; Tang Y; Du J; Liu A; Dai L; Li D; Chen W
    Microb Biotechnol; 2022 Feb; 15(2):577-589. PubMed ID: 34310825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self resistance to the atypical cationic antimicrobial peptide edeine of Brevibacillus brevis Vm4 by the N-acetyltransferase EdeQ.
    Westman EL; Yan M; Waglechner N; Koteva K; Wright GD
    Chem Biol; 2013 Aug; 20(8):983-90. PubMed ID: 23891151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characterization of a bacterial biocontrol strain 1404 and its efficacy in controlling postharvest citrus anthracnose].
    Wang Q; Hu C; Ke F; Huang S; Li Q
    Wei Sheng Wu Xue Bao; 2010 Sep; 50(9):1208-17. PubMed ID: 21090261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Siderophore Production by Rhizosphere Biological Control Bacteria
    Sheng MM; Jia HK; Zhang GY; Zeng LN; Zhang TT; Long YH; Lan J; Hu ZQ; Zeng Z; Wang B; Liu HM
    J Microbiol Biotechnol; 2020 May; 30(5):689-699. PubMed ID: 32482934
    [No Abstract]   [Full Text] [Related]  

  • 9. Antimicrobial peptides produced by Brevibacillus spp.: structure, classification and bioactivity: a mini review.
    Yang X; Yousef AE
    World J Microbiol Biotechnol; 2018 Mar; 34(4):57. PubMed ID: 29594558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity analysis of antagonists from rice-associated bacteria and their application in biocontrol of rice diseases.
    Yang JH; Liu HX; Zhu GM; Pan YL; Xu LP; Guo JH
    J Appl Microbiol; 2008 Jan; 104(1):91-104. PubMed ID: 17850318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-genome analysis and secondary metabolites production of a new strain Brevibacillus halotolerans 7WMA2: A potential biocontrol agent against fungal pathogens.
    Le Han H; Jiang L; Thu Tran TN; Muhammad N; Kim SG; Tran Pham VP; Ng YJ; Khoo KS; Chew KW; Phuong Nguyen TD
    Chemosphere; 2022 Nov; 307(Pt 4):136004. PubMed ID: 35970213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Draft genome sequence of Brevibacillus brevis strain X23, a biocontrol agent against bacterial wilt.
    Chen W; Wang Y; Li D; Li L; Xiao Q; Zhou Q
    J Bacteriol; 2012 Dec; 194(23):6634-5. PubMed ID: 23144389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tostadin, a novel antibacterial peptide from an antagonistic microorganism Brevibacillus brevis XDH.
    Song Z; Liu Q; Guo H; Ju R; Zhao Y; Li J; Liu X
    Bioresour Technol; 2012 May; 111():504-6. PubMed ID: 22391587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Draft Genome Sequence of Biocontrol Bacterium Brevibacillus brevis Strain FJAT-0809-GLX.
    Che J; Liu B; Lin Y; Tang W; Tang J
    Genome Announc; 2013 Apr; 1(2):e0016013. PubMed ID: 23618715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Modifications of Nonribosomal Peptides from Brevibacillus laterosporus MG64 and Investigation of Their Mode of Action.
    Li Z; de Vries RH; Chakraborty P; Song C; Zhao X; Scheffers DJ; Roelfes G; Kuipers OP
    Appl Environ Microbiol; 2020 Nov; 86(24):. PubMed ID: 32978140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome Sequence of Brevibacillus brevis HK544, an Antimicrobial Bacterium Isolated from Soil in Daejeon, South Korea.
    Kim B; Kim YS; Han JW; Choi GJ; Kim H
    Microbiol Resour Announc; 2021 Aug; 10(31):e0041721. PubMed ID: 34351232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of
    Ji C; Li YF; Yao Y; Zhu Z; Mao S
    PeerJ; 2024; 12():e17568. PubMed ID: 38948232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phylogenomic analysis of the Brevibacillus brevis clade: a proposal for three new Brevibacillus species, Brevibacillus fortis sp. nov., Brevibacillus porteri sp. nov. and Brevibacillus schisleri sp. nov.
    Johnson ET; Dunlap CA
    Antonie Van Leeuwenhoek; 2019 Jul; 112(7):991-999. PubMed ID: 30693434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPTLC fingerprint profile, in vitro antioxidant and evaluation of antimicrobial compound produced from Brevibacillus brevis-EGS9 against multidrug resistant Staphylococcus aureus.
    Arumugam T; Senthil Kumar P; Gopinath KP
    Microb Pathog; 2017 Jan; 102():166-172. PubMed ID: 27939872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Genomic Analysis of the Endophytic
    Zeng Q; Xie J; Li Y; Gao T; Zhang X; Wang Q
    Front Genet; 2021; 12():729603. PubMed ID: 34646305
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.